{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:36:39Z","timestamp":1793050599899,"version":"4.5.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.kint.2026.01.011","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:07:59Z","timestamp":1773911279000},"page":"646-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ALDH1A1 is a potential novel target for treatment of ADPKD"],"prefix":"10.1016","volume":"109","author":[{"given":"Liwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Cijiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.01.011_bib1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: core curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2026.01.011_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2026.01.011_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.kint.2025.12.004","article-title":"Aldehyde dehydrogenase 1 A1 regulates the transcription of PD-L1 and its targeting with disulfiram together with PD-L1 immunotherapy synergistically delays cyst growth in ADPKD","volume":"109","author":"Cheng","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.01.011_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306399120","article-title":"Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2","volume":"120","author":"Bai","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2026.01.011_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004421","article-title":"Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy","volume":"10","author":"Baker","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.kint.2026.01.011_bib6","article-title":"A pH-activatable copper-biomineralized proenzyme for synergistic chemodynamic\/chemo-immunotherapy against aggressive cancers","volume":"35","author":"Li","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.kint.2026.01.011_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41419-024-06943-9","article-title":"ALDH1A1 promotes immune escape of tumor cells through ZBTB7B-glycolysis pathway","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:10:54Z","timestamp":1793049054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0085253826000736"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.01.011","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALDH1A1 is a potential novel target for treatment of ADPKD","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.12.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier, Inc., on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}